Start Date:2/2/2023
Start Time:1:30 PM EST
Duration:240 minutes
Abstract:
Join members of the Bionano team for its first-ever Strategy Day event, highlighting the company’s progress towards achieving its mission of transforming the way the world sees the genome. The event will feature presentations from KOLs and management on topics including:
• Market Overview & Growth Plans
• Market Development & Market Access Plans
• Product Development Roadmap
• KOL Panel Discussions around OGM Utility
Panel Moderator: Dan Brennan, Managing Director, Research, Health Care- Life Science and Diagnostic Tools, Cowen
The on-demand replay will be available starting tomorrow 2/3/23.
If you're already registered for the Bionano Strategy Day webcast, click below:
ALREADY REGISTERED?
Speakers & Panelists
- Adam Smith, PhD, FCCMG, Director, Cancer Cytogenetics Laboratory and Clinician Investigator, University Health Network, Toronto, Canada
- Catherine Brownstein, MPH, PhD, Scientific Director, Manton Center for Orphan Disease Research; Assistant Director, Molecular Genetics Core, Boston Children’s Hospital, Boston, MA
- Ben Finlay, PhD, Research Assistant Professor, NCI-Designated Cancer Center; Scientific Director, Tumor Analysis, Sanford Burnham Prebys, San Diego, CA
- Rashmi Kanagal-Shamanna, MD, Director, Microarray Facility, Department of Molecular Diagnostic Laboratory, Division of Hematopathology Department, University of Texas MD Anderson Cancer Center, Houston, TX
- Ravindra Kolhe, MD, PhD, FCAP, Professor and Interim Chair, Pathology, Leon Henri Charbonnier Endowed Chair of Pathology, Augusta University; Associate Director for Genomics, Georgia Cancer Center, Augusta, GA
- Gordana Raca, MD, PhD, FACMG, Director, Clinical Cytogenomics Laboratory, Center for Personalized Medicine, Children’s Hospital of Los Angeles, Los Angeles, CA
- Erik Holmlin, PhD, President & CEO, Bionano Genomics
- Alka Chaubey, PhD, FACMG, Chief Medical Officer, Bionano Genomics
- Mark Oldakowski, Chief Operating Officer, Bionano Genomics
- Chris Stewart, Chief Financial Officer, Bionano Genomics
- Alex Hastie, PhD, Vice President, Scientific and Clinical Affairs, Bionano Genomics
|
|
Email Address
|
|
First Name
|
|
Last Name
|
|
Company
|
|
Job Title
|
|
Country
|
|
|
|